Loading...
Effective treatment of severe COVID-19 patients with tocilizumab
After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through monocl...
Na minha lista:
| Udgivet i: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245089/ https://ncbi.nlm.nih.gov/pubmed/32350134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2005615117 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|